 |
 |
 |
 |
 |
Structural Biology in Cancer Drug Design is the theme of the spring 2008 mini-Symposium organized by the University of Colorado Cancer Center. The Symposium will be held in Research Hensel Phelps Auditorium-West on March 21st, 2008. Leading structural biologists will present their breakthrough studies at this meeting, which focuses on key aspects of structure based drug discovery and advances in cancer medicine.
The Symposium will provide an excellent opportunity to bring together scientists working in all areas of basic cancer research and clinicians to discuss progress in cancer drug design, target selection and the impact of the structural biology approaches on development of novel therapeutics for cancer.
The Symposium comprises four sessions, which cover topics such as mechanisms of EGFR activation, antibody and small molecule inhibitors of EGFR, protein tyrosine kinase regulation, development of tyrosine kinase inhibitors, NMR- and fragment-based approaches to drug design, scaffold-based drug discovery, and studies aimed at the discovery of new targets and anti-tumor therapeutics.
Lunch is included with registration. The registration deadline is March 7.
Elan Eisenmesser
Tatiana Kutateladze
Rui Zhao
download Symposium flyer as portable document
